A patient who used an unapproved peptide labelled as the weight-loss drug retatrutide suffered a potentially fatal torn oesophagus after experiencing uncontrollable vomiting, according to a warning issued by the Therapeutic Goods Administration (TGA). Laboratory testing revealed the product contained no retatrutide, but instead held an exceptionally high dose of undeclared semaglutide.
TGA Warning Over Black Market Retatrutide and Oesophageal Tears
According to the TGA’s safety advisory, laboratory analysis showed the black market vial contained semaglutide—the active pharmaceutical ingredient in Ozempic and Wegovy—at roughly eight times the concentration found in TGA-assessed products. Melbourne gastroenterologist Darcy Holt, who has treated patients experiencing adverse effects from counterfeit injectables, stated that a ruptured oesophagus is a severe medical emergency. According to Dr. Holt, stomach contents can leak into the chest cavity near the heart and main blood vessels during a tear, causing severe infection and inflammation that is almost universally fatal without prompt medical attention. He noted that high doses of these substances trigger extreme nausea and forceful vomiting, which directly causes the structural damage.
Hidden Dangers of Black Market Injectable Peptides
Testing conducted by the ABC in partnership with the University of Queensland previously found that black market vials of retatrutide frequently carried doses far higher than their product labels indicated. Retatrutide itself remains unapproved by the TGA or any comparable international regulator and is currently limited strictly to human clinical trials. TGA chief medical advisor Robyn Langham stated that the primary danger of unapproved peptide products lies in consumers having no way of knowing the actual substance, dose, or sterility of what is inside the vial. According to Dr. Langham, non-sterile manufacturing processes significantly elevate the risk of severe infections and immune responses, including anaphylaxis.
Rising Popularity of Unregulated Weight-Loss Drugs
Medical professionals report a sharp rise in patients disclosing the use of unapproved peptides. According to Dr. Holt, use of substances like retatrutide shifted over a three-to-six-month period from an extremely rare disclosure to a routine mention on patient medication lists. Beyond oesophageal trauma, Dr. Holt warned that patients taking unapproved peptides have also suffered life-threatening complications such as liver toxicity and severe secretory diarrhoea.
Frequently Asked Questions
What is retatrutide?
Retatrutide is an investigational peptide currently undergoing clinical trials in humans. According to the TGA, it has not been approved for public use by any regulatory body.
Why did the black market product cause a torn oesophagus?
According to Dr. Darcy Holt, the counterfeit product contained an unregulated, exceptionally high dose of semaglutide that triggered extreme nausea and forceful vomiting, which can rupture the tube carrying food to the stomach.
What contaminants are found in unapproved peptides?
According to the TGA, unapproved injectable peptides often lack sterile manufacturing standards, carrying risks of unknown substances, incorrect dosages, bacterial contaminants, and toxins that can cause severe infections or anaphylaxis.
Have you encountered unapproved peptides online or want to share your experience? Join the discussion below or subscribe to our health newsletter for ongoing updates.
Keep reading